Walleye Capital’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $937K | Buy |
21,696
+5,347
| +33% | +$231K | ﹤0.01% | 861 |
|
|
2025
Q1 | $565K | Buy |
16,349
+6,521
| +66% | +$225K | ﹤0.01% | 1035 |
|
|
2024
Q4 | $270K | Buy |
+9,828
| New | +$270K | ﹤0.01% | 1397 |
|
|
2024
Q3 | – | Sell |
-77,613
| Closed | -$1.97M | – | 2498 |
|
|
2024
Q2 | $1.97M | Buy |
77,613
+55,705
| +254% | +$1.41M | ﹤0.01% | 821 |
|
|
2024
Q1 | $677K | Buy |
+21,908
| New | +$677K | ﹤0.01% | 1240 |
|
|
2023
Q4 | – | Sell |
-51,872
| Closed | -$1.37M | – | 2205 |
|
|
2023
Q3 | $1.37M | Buy |
51,872
+19,047
| +58% | +$502K | ﹤0.01% | 775 |
|
|
2023
Q2 | $565K | Buy |
+32,825
| New | +$565K | ﹤0.01% | 958 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2148 |
|
|
2022
Q1 | – | Sell |
-52,953
| Closed | -$883K | – | 2217 |
|
|
2021
Q4 | $883K | Buy |
+52,953
| New | +$883K | 0.03% | 650 |
|
|
2021
Q2 | – | Sell |
-4,156
| Closed | -$256 | – | 1320 |
|
|
2021
Q1 | $256 | Buy |
+4,156
| New | +$256 | 0.01% | 818 |
|